Shell Asset Management CO Dexcom Inc Transaction History

Shell Asset Management CO

$2.26 Billion
Q1 2024

A detailed history of Shell Asset Management CO transactions in Dexcom Inc stock. As of the latest transaction made, Shell Asset Management CO holds 39,240 shares of DXCM stock, worth $4.41 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

39,240

Previous 37,310 5.17%

Holding current value

$4.41 Million

Previous $4.63 Million 17.56%

% of portfolio

0.24%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $220,444 - $270,393	1,930 Added 5.17%	39,240 $5.44 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $734,291 - $1.21 Million	-9,727 Reduced 20.68%	37,310 $4.63 Million
Q3 2023 Nov 08, 2023	SELL	$86.06 - $137.93 $92,686 - $148,550	-1,077 Reduced 2.24%	47,037 $4.39 Million
Q2 2023 Jul 28, 2023	BUY	$112.47 - $130.98 $2.45 Million - $2.86 Million	21,821 Added 82.99%	48,114 $6.18 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $33,800 - $39,949	-325 Reduced 1.22%	26,293 $3.06 Million

Q4 2022 Feb 07, 2023	SELL	$84.98 - $122.67 $385,214 - $556,063	-4,533 Reduced 14.55%	26,618 $3.01 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $572,395 - $706,067	-7,497 Reduced 19.4%	31,151 $2.51 Million
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $2.05 Million - $4.01 Million	30,188 Added 356.83%	38,648 $2.88 Million
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $60,305 - $83,458	-641 Reduced 7.04%	8,460 $4.33 Million
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $137,142 - $171,937	1,056 Added 13.13%	9,101 $4.89 Million
Q3 2021 Nov 04, 2021	SELL	$106.71 - $143.18 $15,259 - $20,474	-143 Reduced 1.75%	8,045 $4.4 Million
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $10,204 - $13,599	-126 Reduced 1.52%	8,188 $3.5 Million
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $110,566 - $136,580	-1,304 Reduced 13.56%	8,314 $2.99 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $301,548 - $403,997	3,866 Added 67.21%	9,618 $3.56 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $271,343 - $320,890	2,841 Added 97.6%	5,752 $2.37 Million
Q2 2020 Aug 10, 2020	SELL	$62.68 - $105.34 $70,828 - $119,034	-1,130 Reduced 27.96%	2,911 $1.18 Million
Q1 2020 May 11, 2020	SELL	$47.79 - $75.63 $30,633 - $48,478	-641 Reduced 13.69%	4,041 $1.09 Million
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $55,845 - $87,367	-1,525 Reduced 24.57%	4,682 $1.02 Million
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $162,613 - $227,331	-5,841 Reduced 48.48%	6,207 $930,000
Q1 2019 May 09, 2019	SELL	$28.07 - $38.18 $113,627 - $154,552	-4,048 Reduced 25.15%	12,048 $1.44 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $145,934 - $202,059	5,407 Added 50.58%	16,096 $1.93 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $249,588 - $392,500	10,689 New	10,689 $1.53 Million
Q4 2017 Feb 09, 2018	SELL	$11.12 - $15.38 $55,933 - $77,361	-5,030 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$11.36 - $18.98 $57,140 - $95,469	5,030	5,030 $246,000

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Dexcom Inc Transaction History